Speciality Chemicals

Tanfac Industries shares rally 13% on pact with Japanese chemical firm

On Thursday, shares of Tanfac Industries, an Indian speciality fluoride chemical manufacturer soared by 13.1 per cent at Rs 2,399 a piece intraday on the BSE

Anupam Rasayan sprints 7% on signing $90-mn LoI with Japanese MNC

Anupam Rasayan will be the first company in India to manufacture these key molecules within the country

Recovery in exports amid rising chemical prices to drive SRF stock

The demand-supply imbalance and margin pressures would be a key monitorable in the near to medium-term

PCBL plans to acquire 100% in Aquapharm Chemicals for Rs 3,800 cr

Carbon black and speciality chemicals major PCBL Ltd on Tuesday announced plans to acquire 100 per cent in Aquapharm Chemicals Pvt Ltd (ACPL) for an aggregate consideration of Rs 3,800 crore. Subject to the agreed adjustment, the acquisition will be financed through a mix of internal accruals and external fundraising by the company and its associates, the company informed the bourses. This acquisition marks PCBL's foray into global speciality segments of water treatment chemicals and oil & gas chemicals, the company said. The transaction will be financed through a combination of internal accruals and external fund raise, it said. ACPL is a Pune-based globally top three leading specialty chemicals company, manufacturing and water treatment chemicals. The company has manufacturing facilities in India, the US, and Saudi Arabia. Overseas plants are being operated through subsidiaries. ACPL topline was Rs 2,045 crore and EBIDTA was Rs 417 crore in 2022-23. The transaction is subject t

TMS Ep516: Tata and Haldiram's, 7nm chips, markets, India or Bharat

Why does Tata want Haldiram's on its plate? Is China winning the chip war? Is it time to bargain hunt speciality chemical stocks? India or Bharat: What the Constituent Assembly decided. Answers here

This chemical stock has crashed 15% in one month; is reversal on cards?

Clean Science and Technology had made a solid debut on Dalal Street on July 19 as the stock had listed at Rs 1,784.40 on BSE, a 98.26 per cent premium to its issue price of Rs 900

Rossari to acquire Tristar Intermediates at enterprise value of Rs 120 cr

Rossari Biotech Ltd, a speciality chemicals manufacturer, on Sunday announced the acquisition of Tristar Intermediates at an enterprise value of Rs 120 crore. The board of the company has approved the acquisition of Tristar Intermediates, a move which will help Rossari Biotech expand its product portfolio, primarily in the personal care segment, a joint statement said. As per the agreement and subject to customary closing conditions, Rossari will be acquiring 100 per cent equity share capital of Tristar Intermediates, it added. "76 per cent of the equity share capital will be acquired upon closure of the transaction, and the balance 24% over the next three years. The total enterprise value of the transaction is Rs 120 crore," it said. Rossari plans to fund the investment through cash on the balance sheet and doesn't intend to raise any debt for this acquisition. Established in 1998, Tristar Intermediates operates in the field of Preservatives, Aroma Chemicals, and Home & Personal

Tatva Chintan Pharma IPO fully subscribed within hours of opening

The initial public offer of specialty chemical manufacturing company Tatva Chintan Pharma Chem was fully subscribed within the first few hours of opening on the first day of subscription on Friday

Anupam Rasayan bags orders worth Rs 540 cr to supply speciality chemicals

Anupam Rasayan on Wednesday said it has bagged orders worth Rs 540 crore from two multinational companies for supplying speciality chemicals

Anupam Rasayan hits 52-week high on securing order worth Rs 1,100 crore

The company will be providing multiple products to the multinational firm for the next five years

Laxmi Organic makes decent debut, lists at 20% premium over issue price

The initial public offer (IPO) of Laxmi Organic Industries had received a robust response from the investors

Rossari Biotech slips 5% after board approves Rs 300 cr preferential issue

Rossari proposes to utilise the net proceeds to evaluate and invest in inorganic growth opportunities, within its core chemistries, with a view to diversify its product portfolio

High valuation vs growth prospects: Should you bid for Anupam Rasayan IPO?

While most analysts have assigned a Subscribe rating to the IPO, they have also flagged valuations concerns

Deepak Nitrite: Analysts see further upside despite 135% rally in 6 months

Deepak Nitrite got a shot in the arm on Thursday when the government announced to extend anti-dumping duty on phenol exported from the European Union and Singapore till June 7, 2021

Tata Chem, Alkyl Amines: These chemical stocks may rally another 25%

With the Tata Chemicals' stock continuously witnessing buying momentum in the overbought condition of Relative Strength Index (RSI), the strength remains intact

Speciality chemicals firms see gains from coronavirus scare as orders rise

Supply disruption in China, new orders, and expansions are key positives

Indian speciality chemicals firms to benefit from China's stricter green norms

The crackdown on polluters has opened up a window of opportunity for Indian manufacturers, who are investing more to grow capacity